FALCONBIO builds Smart Bacteria: a pioneering drug delivery system to fight cancer.

Current cancer drugs target normal cells along with cancer cells causing severe side-effects, suffering, and patient death. Reduced drug effectiveness leads to 50% increased mortality leading to drug failures. FALCONBIO develop ingestible cancer therapeutic solutions with their proprietary Smart Bacteria (SB).

Their SB are engineered to specifically seek, sense and destroy cancer cells completely without damaging the health of the patient. FALCONBIO is in negotiations with 3 pharma giants to co-develop SB-based cancer therapies for colorectal cancer. Their vision is to revolutionize cancer therapy by 2025.